Tiziana Life Sciences (TLSA)
(Delayed Data from NSDQ)
$2.09 USD
-0.24 (-10.30%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $2.08 -0.01 (-0.48%) 6:36 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TLSA 2.09 -0.24(-10.30%)
Will TLSA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TLSA based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for TLSA
Tesla: The Robotaxi Revolution Begins In Austin
Lucid Is Now Shipping Adapters That Let Customers Access Elon Musk-Led Tesla's Supercharger Network
Tiziana Life Sciences (TLSA) Receives Buy Rating with Promising Outlook | TLSA Stock News
Tiziana Life Sciences initiated with bullish view at Lucid Capital, here's why
TLSA: Tiziana Life Sciences Unveils Promising Alzheimer's Treatment Findings | TLSA Stock News